Talaris Therapeutics, Inc. Human Resources Contracts & Agreements
14 Contracts & Agreements
- Bonus & Incentive Agreements (7 contracts)
- Change of Control Agreements (1)
- Compensation Agreements (3)
- Employment Agreements (2)
- Transition Agreements (1)
- Amended Non-Employee Director Compensation Policy (Filed With SEC on May 13, 2024)
- Forms of Restricted Stock Unit Grant Notice and Award Agreement under Tourmaline Bio, Inc. 2023 Equity Incentive Plan (Filed With SEC on October 20, 2023)
- Forms of Option Grant Notice, Option Agreement and Notice of Exercise under Tourmaline Bio, Inc. 2023 Equity Incentive Plan (Filed With SEC on October 20, 2023)
- Tourmaline Bio, Inc. 2023 Equity Incentive Plan (Filed With SEC on October 20, 2023)
- 2022 Equity Incentive Plan of Tourmaline Bio, Inc., and form of award agreements thereunder (Filed With SEC on July 20, 2023)
- Transition Agreement, by and between the Registrant and Suzanne T. Ildstad, dated August 13, 2022 (Filed With SEC on November 10, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on May 3, 2021)
- 2021 Stock Option and Incentive Plan and form of award agreements thereunder (Filed With SEC on May 3, 2021)
- Deferred Compensation Plan for Non-Employee Directors of the Registrant (Filed With SEC on April 16, 2021)
- Employment Agreement, by and between the Registrant and Suzanne T. Ildstad, dated November 1, 2018 (Filed With SEC on April 16, 2021)
- Employment Agreement, by and between the Registrant and Scott Requadt, dated November 1, 2018 (Filed With SEC on April 16, 2021)
- Severance and Change in Control Plan (Filed With SEC on April 16, 2021)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on April 16, 2021)
- Second Amended and Restated 2018 Equity Incentive Plan, as amended, and form of award agreements thereunder (Filed With SEC on April 16, 2021)
